Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07573969
PHASE3

Adding Dexmedetomidine Versus Ketamine to Bupivacaine in Fluoroscopy Guided Caudal Analgesia for Lumbosacral Surgeries

Sponsor: Ain Shams University

View on ClinicalTrials.gov

Summary

This study will evaluate the effect of adding dexmedetomidine to bupivacaine compared to ketamine in the caudal block on perioperative analgesia in patients undergoing lumbosacral surgeries under general anesthesia.

Official title: Effect of Adding Dexmedetomidine Versus Ketamine to Bupivacaine in Fluoroscopy Guided Caudal Analgesia for Lumbosacral Surgeries Under General Anaesthesia; a Randomised Controlled Double Blinded Study

Key Details

Gender

All

Age Range

21 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

72

Start Date

2026-05

Completion Date

2027-05

Last Updated

2026-05-07

Healthy Volunteers

No

Interventions

DRUG

Group C (plain bupivacaine (0.125%))

The patients will receive 20ml plain bupivacaine (0.125%) in the caudal block

DRUG

Group D (plain bupivacaine (0.125%) + 2μg/kg dexmedetomidine)

The patients will receive 20ml plain bupivacaine (0.125%) + 2μg/kg dexmedetomidine in the caudal block

DRUG

Group K (plain bupivacaine (0.125%) + 1mg/kg ketamine)

The patients will receive 20ml plain bupivacaine (0.125%) + 1mg/kg ketamine in the caudal block

Locations (1)

Ain Shams University hospitals

Cairo, Egypt